A Novel Graphene-Based Nanomaterial for the Development of a Pelvic Implant to Treat Pelvic Organ Prolapse
Graphene is the wonder material of the 21st century, promising cutting-edge advancements in material science with significant applications across all industries. This study investigates the use of a graphene-based nanomaterials (GBNs) ans trade-registered Hastalex , as novel materials for surgical i...
Gespeichert in:
Veröffentlicht in: | Journal of functional biomaterials 2024-11, Vol.15 (11), p.351 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Graphene is the wonder material of the 21st century, promising cutting-edge advancements in material science with significant applications across all industries. This study investigates the use of a graphene-based nanomaterials (GBNs) ans trade-registered Hastalex
, as novel materials for surgical implants aimed at treating pelvic organ prolapse (POP). This study investigates the mechanical properties and physicochemical characteristics of the material, mainly focusing on its potential to address the limitations of existing polypropylene (PP) implants, which has been associated with numerous complications and banned across multiple countries. Attenuated total reflectance Fourier transform infrared (ATR-FTIR) confirmed the bonding between functionalised graphene oxide (FGO) and the base polymer chain. Hastalex exhibited excellent mechanical properties with 58 N/mm
maximum tensile strength at break and 701% elongation at break, whilst maintaining its shape with no plastic deformation. These results were comparable to that of sheep pelvic muscular tissue. Hastalex demonstrated its hydrophilic properties from contact angle measurements. Scanning electron microscopy (SEM) and atomic force microscopy (AFM) showed a uniform plane with surface nanotopography, promoting cell-to-material interaction. The results confirmed the suitability of Hastalex in the development of a new pelvic membrane to treat POP. |
---|---|
ISSN: | 2079-4983 2079-4983 |
DOI: | 10.3390/jfb15110351 |